PDS Biotechnology Corp (PDSB) Implied Volatility Current

Tracking PDSB implied volatility helps you identify when options premiums on PDS Biotechnology Corp are historically cheap or expensive, and where the best trades are hiding. PDS Biotechnology Corp implied volatility reflects the market's expectation of future price movement: when PDSB IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor PDS Biotechnology Corp's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For PDSB, tracking metrics like PDSB IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on PDSB signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma.

In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where PDSB implied volatility sits today versus where it has been. Our scanner ranks PDS Biotechnology Corp implied volatility against its historical range, surfaces extremes in PDSB IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether PDS Biotechnology Corp IV is rich or cheap — measure it, then act on it.